New device aims to make prostate cancer diagnosis faster and more precise
NCT ID NCT05362032
Summary
This study is testing a new medical device called the OmnEcoil system, which combines two prostate cancer diagnostic steps into one. Currently, men with suspected prostate cancer typically undergo an MRI scan and then a separate biopsy procedure. This device aims to perform both the imaging and the tissue sampling during a single session. The research will check if the device works properly, is safe to use, and is comfortable for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
OHSU Knight Cancer Institute
Portland, Oregon, 97239, United States
Conditions
Explore the condition pages connected to this study.